Journal of Cataract & Refractive Surgery
Volume 30, Issue 7 , Pages 1435-1444 , July 2004

Accommodation measurements in a prepresbyopic and presbyopic population

  • Lisa A Ostrin
    • ,
  • Adrian Glasser, PhD

      Affiliations

    • Corresponding Author InformationReprint requests to Adrian Glasser, PhD, College of Optometry, University of Houston, 4901 Calhoun Road, Houston, Texas 77204, USA

,Accepted 24 October 2003.

References 

  1. Keeney AH, Hagman RE, Fratello CJ. Dictionary of Ophthalmic Optics. Newton, MA, Butterworth-Heinemann, 1995; 4
  2. Hamasaki D, Ong J, Marg E. The amplitude of accommodation in presbyopia. Arch Am Acad Optom. 1956;33:3–14
  3. Glasser A, Kaufman PL. Accommodation and Presbyopia. In:  Kaufman PL,  Alm A editor. Adler's Physiology of the Eye; Clinical Application. 10th ed. St Louis, MO: Mosby; 2003;p. 197–233
  4. Helmholtz H. Mechanism of accommodation. In:  Southall JPC editors. Helmholtz's Treatise on Physiological Optics, translated from the third German edition. New York, NY: Dover; 1962;p. 143–173
  5. Glasser A, Kaufman PL. The mechanism of accommodation in primates. Ophthalmology. 1999;106:863–872
  6. London R. Amplitude of accommodation. In:  Eskridge JB,  Amos JF,  Bartlett JD editor. Clinical Procedures in Optometry. Philadelphia, PA: JB Lippincott; 1991;p. 69–71
  7. Duane A. Normal values of the accommodation at all ages. JAMA. 1912;59:1010–1013
  8. Gimpel G, Doughty MJ, Lyle WM. Large sample study of the effects of phenylephrine 2.5% eyedrops on the amplitude of accommodation in man. Ophthalmic Physiol Opt. 1994;14:123–128
  9. Rosenfield M, Cohen AS. Repeatability of clinical measurements of the amplitude of accommodation. Ophthalmic Physiol Opt. 1996;16:247–249
  10. Atchison DA, Charman WN, Woods RL. Subjective depth-of-focus of the eye. Optom Vis Sci. 1997;74:511–520
  11. Thompson HS. The pupil. In: Hart WM Jr, Adler's Physiology of the Eye; Clinical Application, 9th ed. St Louis, MO, Mosby Year Book, 1992; 412–441
  12. Atchison DA, Capper EJ, McCabe KL. Critical subjective measurement of amplitude of accommodation. Optom Vis Sci. 1994;71:699–706
  13. Lindstrom RL. Food and Drug Adminsistration study update; one-year results from 671 patients with the 3M multifocal intraocular lens. Ophthalmology. 1993;100:91–97
  14. Schachar RA. Cause and treatment of presbyopia with a method for increasing the amplitude of accommodation. Ann Ophthalmol. 1992;24:445–447 452
  15. Schachar RA. The correction of presbyopia. Int Ophthalmol Clin. 2001;41(2):53–70
  16. Cumming JS, Slade SG, Chayet A. Clinical evaluation of the model AT-45 silicone accommodating intraocular lens; results of feasibility and the initial phase of a Food and Drug Administration clinical trial; the AT-45 Study Group. Ophthalmology. 2001;108:2005–2009 discussion by TP Werblin, 2010
  17. Kuchle M, Nguyen NX, Langenbucher A, et al.  Implantation of a new accommodative posterior chamber intraocular lens. J Refract Surg. 2002;18:208–216
  18. Langenbucher A, Huber S, Nguyen NX, et al.  Measurement of accommodation after implantation of an accomodating posterior chamber intraocular lens. J Cataract Refract Surg. 2003;29:677–685
  19. Langenbucher A, Seitz B, Huber S, et al.  Theoretical and measured pseudophakic accommodation after implantation of a new accommodative posterior chamber intraocular lens. Arch Ophthalmol. 2004;121:1722–1727
  20. Malecaze FJ, Gazagne CS, Tarroux MC, Gorrand J-M. Scleral expansion bands for presbyopia. Ophthalmology. 2001;108:2165–2171
  21. Mathews S. Scleral expansion surgery does not restore accommodation in human presbyopia. Ophthalmology. 1999;106:873–877
  22. Bartlett JD, Jaanus SD, Fiscella RG, Sharir M. Ocular hypotensive drugs. In:  Bartlett JD,  Jaanus SD editor. Clinical Ocular Pharmacology. 4th ed. Boston, MA: Butterworth-Heinemann; 2001;p. 167–218
  23. Croft MA, Oyen MJ, Gange SJ, et al.  Aging effects on accommodation and outflow facility responses to pilocarpine in humans. Arch Ophthalmol. 1996;114:586–592
  24. Abramson DH, Franzen LA, Coleman DJ. Pilocarpine in the presbyope; demonstration of an effect on the anterior chamber and lens thickness. Arch Ophthalmol. 1973;89:100–102
  25. Mordi J, Tucker J, Charman WN. Effects of 0.1% cyclopentolate or 10% phenylephrine on pupil diameter and accommodation. Ophthalmic Physiol Opt. 1986;6:221–227
  26. Fincham EF. The coincidence optometer. Proc Phys Soc (Lond). 1937;49:456–468
  27. Kaufman PL. Scleral expansion surgery for presbyopia. Ophthalmology. 2001;108:2161–2162 [guest editorial]
  28. Wold JE, Hu Chen S, Glasser A. Subjective and objective measurement of human accommodative amplitude. J Cataract Refract Surg. 2003;29:1878–1888
  29. Melikian HE, Lieberman TW, Leopold IH. Ocular pigmentation and pressure and outflow responses to pilocarpine and epinephrine. Am J Ophthalmol. 1971;72:70–73
  30. Berger IB, Spitzberg LA, Nnadozie J, et al.  Testing the FOCOMETER—a new refractometer. Optom Vis Sci. 1993;70:332–338
  31. Croft MA, Kaufman PL, Crawford KS, et al.  Accommodation dynamics in aging rhesus monkeys. Am J Physiol. 1998;275(6, pt 2):R1885–R1897
  32. Koretz JF, Kaufman PL, Neider MW, Goeckner PA. Accommodation and presbyopia in the human eye—aging of the anterior segment. Vision Res. 1989;29:1685–1692
  33. Lyle WM, Bobier WR. Effects of topical anesthetics on phenylephrine-induced mydriasis. Am J Optom Physiol Opt. 1977;54:276–281
  34. Seddon JM, Sahagian CR, Glynn RJ, et al.  Evaluation of an iris color classification system. Invest Ophthalmol Vis Sci. 1990;31:1592–1598
  35. Eriksson AW, Fellman J, Nieminen H, Forsius H. Influence of age on the position and size of the iris frill and the pupil. Acta Ophthalmol. 1965;43:629–641
  36. Manny RE, Fern KD, Zervas HJ, et al.  1% cyclopentolate hydrochloride (another look at the time course of cycloplegia using an objective measure of the accommodative response). Optom Vis Sci. 1993;70:651–665
  37. Lovasik JV. Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide. Am J Optom Physiol Opt. 1986;63:787–803
  38. Miranda MN. Residual accommodation; a comparison between cyclopentolate 1% and a combination of cyclopentolate 1% and tropicamaide 1%. Arch Ophthalmol. 1972;87:515–517
  39. Harris LS, Galin MA. Effect of ocular pigmentation on hypotensive response to pilocarpine. Am J Ophthalmol. 1971;72:923–925
  40. Hung GK, Ciuffreda KJ, Rosenfield M. Proximal contribution to a linear static model of accommodation and vergence. Ophthalmic Physiol Opt. 1996;16:31–41
  41. Bruce AS, Atchison DA, Bhoola H. Accommodation-convergence relationships and age. Invest Ophthalmol Vis Sci. 1995;36:406–413
  42. McLeod SD. The challenge of presbyopia. Arch Ophthalmol. 2002;120:1572–1574 [editorial]

☆ Presented in part at the annual meetings of the American Academy of Optometry, Philadelphia, Pennsylvania, December 2001, and the Association for Research in Vision and Ophthalmology, May 2002, Ft. Lauderdale, Florida, USA.

☆☆ Supported in part by grants from Pharmacia, Groningen, The Netherlands, NEI grants 1 RO1 EY 014651-01 to A.G. and NEI grant EYO 7088-15 to the University of Houston College of Optometry.

★ Neither author has a financial or proprietary interest in any material or method mentioned.

★★ In Focus, Houston, Texas, USA, donated the focometer for this study, and Alcon Laboratories, Ft. Worth, Texas, USA, provided pilocarpine 6%.

PII: S0886-3350(04)00069-0

doi: 10.1016/j.jcrs.2003.12.045

Journal of Cataract & Refractive Surgery
Volume 30, Issue 7 , Pages 1435-1444 , July 2004

Article Tools

* Image Usage & Resolution